GE HealthCare Technologies Inc.

NASDAQ:GEHC

Medical - Healthcare Information Services

Healthcare
$83.66 +0.74%

+$0.45 today

Market cap
$37.83B
Beta
0.86
P/E (TTM)
18.7
EPS (TTM)
$3.30
Dividend yield
0.23%
52W Low $58.75High $89.77

Volume 3.65M

Average 4.84M

GEHC Financing Cash Flow

Net cash exchanged with lenders and shareholders through borrowing, repayments, buybacks, and dividends.

GE HealthCare Technologies Inc.NASDAQ: GEHC

Financing Cash Flow · Q2 FY2026 · quarter ended Jun 2026

Financing cash flow turns negative

Q2 FY2026 financing cash flow was -$446M, compared with $1.36B a year earlier. Trailing-twelve-month financing cash flow was -$883M.

Context

  • Financing cash flow amounted to 3.0% of revenue in FY2025, unchanged from a year earlier.
  • Financing cash flow increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly financing cash flow holds near -$446M or moves back toward the trailing-twelve-month quarterly average of -$220.75M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
-$446M-2223.8% QoQ
Last fiscal yearDec 2025
$617M+207.7% YoY
LTMJun 2026
-$883M-224.0% YoY
Financing Cash Flow past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-132.8%——
1 year+207.7%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Financing Cash Flow history

USD · from the cash flow

Latest · FY2025
617M USD
Year-over-year change
+207.7%

Financing Cash Flow vs competitors

How GEHC compares with its peers on the latest reported figures

  • Peers report in different currencies, so financing cash flow is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -224.0% is the 3rd highest of 6, against a peer median of -226.3%.
  • Financing cash flow amounts to 4.4% of revenue for GEHC, versus a peer median of 9.9%.
GEHC Competitors
Financing Cash Flow for GEHC and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ABTAbbott LaboratoriesLTM Jun 2026$10.64B USD+261.5%-6.2%22.8%
MDTMedtronic plcLTM Jul 2026$3.71B USD-25.9%-1.4%9.9%
SYKStryker CorporationLTM Jun 2026$3.04B USD-226.3%—11.8%
PHGKoninklijke Philips N.V.LTM Jun 2026€1.57B EUR-416.3%-41.2%8.9%
BSXBoston Scientific CorporationLTM Jun 2026$958M USD-940.4%-10.3%4.6%
GEHCGE HealthCare Technologies Inc.LTM Jun 2026$883M USD-224.0%—4.4%
Peer median (excluding GEHC) —-226.3%-8.3%9.9%

Competitors are the stored peer set for GEHC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income2.28B1.95B1.62B2.05B2.15B
Depreciation & Amortization625M633M610M580M578M
Deferred Income Tax600M563M743M531M0
Stock-Based Compensation76M67M114M125M130M
Change in Working Capital(1.37B)(293M)22M(59M)(357M)
Accounts Receivables(1.16B)(440M)(171M)(150M)(216M)
Inventory(435M)(402M)111M(81M)(142M)
Accounts Payables263M481M(13M)126M90M
Other Working Capital(42M)68M95M46M(89M)
Other Non-Cash Items(599M)(806M)(1.01B)(1.28B)(517M)
Operating Cash Flow1.61B2.11B2.1B1.95B1.99B
Capital Expenditures(248M)(310M)(387M)(401M)(482M)
Acquisitions (Net)(1.48B)0(147M)(313M)0
Purchases of Investments0(59M)(48M)(40M)(118M)
Sales of Investments00000
Other Investing Activities(32M)(29M)24M(160M)(447M)
Investing Cash Flow(1.76B)(398M)(558M)(914M)(1.05B)
Debt Repayment(12M)8.2B1.14B(423M)967M
Common Stock Issued00033M37M
Common Stock Repurchased0000(200M)
Dividends Paid00(41M)(55M)(64M)
Other Financing Activities(251M)(9.03B)(1.58B)(128M)(123M)
Financing Cash Flow(263M)(822M)(478M)(573M)617M
Effect of Forex Changes(34M)(3M)(10M)(77M)64M
Net Change in Cash(451M)890M1.06B387M1.62B
Free Cash Flow1.36B1.8B1.71B1.55B1.51B

GE HealthCare Technologies Inc.

NASDAQ:GEHC

Intrinsic Alpha fair value

Locked

Current Price

$83.66

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.